Methylation of the ABL1 promoter in chronic myelogenous leukemia: Lack of prognostic significance

Blood

Volumn 93, Issue 6, 1999, Pages 2075-2080

  Issa, Jean Pierre J ^a   Kantarjian, Hagop ^b   Mohan, Avinash ^b   O'Brien, Susan ^b   Cortes, Jorge ^b   Pierce, Sherry ^b   Talpaz, Moshe ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADULT; ARTICLE; CHROMOSOME TRANSLOCATION; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; DISEASE MARKER; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PATHOGENESIS; PATHOPHYSIOLOGY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN METHYLATION;

EID: 0033559955     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.6.2075.406k29_2075_2080     Document Type: Article

References (17)

1. Cortes JE, Talpaz M, Kantarjian H: Chronic myelogenous leukemia: A review. Am J Med 100:555, 1996
2. Jones RJ: Biology and treatment of chronic myeloid leukemia. Curr Opin Oncol 9:3, 1997
3. Rowley JD: The Philadelphia chromosome translocation. A paradigm for understanding leukemia. Cancer 65:2178, 1990
4. Chissoe SL, Bodenteich A, Wang YF, Wang YP, Burian D, Clifton SW, Crabtree J, Freeman A, Iyer K, Jian L, Ma Y, McLaury H-J, Pan H-Q, Sarhan OH, Toth S, Wang Z, Zhang G, Heisterkamp N, Groeffen J, Roe B: Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 27:67, 1995
5. Zion M, Ben-Yehuda D, Avraham A, Cohen O, Wetzler M, Melloul D, Ben-Neriah Y: Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc Natl Acad Sci USA 91:10722, 1994
6. Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB: Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients. Am J Clin Pathol 106:442, 1996
7. Diamond J, Goldman JM, Melo JV: BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia. Blood 85:2171, 1995
8. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JPJ: Alterations in DNA methylation - A fundamental aspect of neoplasia. Adv Cancer Res 72:141, 1997
9. Issa JPJ, Baylin SB, Herman JG: DNA Methylation changes in hematologic malignancies: Biologic and clinical implications. Leukemia 11:S7, 1997
10. Jones PA: DNA methylation errors and cancer. Cancer Res 56:2463, 1996
11. Ben-Yehuda D, Krichevsky S, Rachmilewitz EA, Avraham A, Palumbo GA, Frassoni F, Sahar D, Rosenbaum H, Paltiel O, Zion M, Ben-Neriah Y: Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia. Blood 90:4918, 1997
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
13. Kantaijian HM, O'Brien S, Anderlini P, Talpaz M: Treatment of myelogenous leukemia: Current status and investigational options. Blood 87:3069, 1996
14. Schaefer-Rego KE, Leibowitz D, Mears JG: Chromatin alterations surrounding the BCR/ABL fusion gene in K562 cells. Oncogene 5:1669, 1990
15. Doerfler W: The insertion of foreign DNA into mammalian genomes and its consequences: A concept in oncogenesis. Adv Cancer Res 66:313, 1995
16. Kim CG, Epner EM, Forrester WC, Groudine M: Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region. Genes Dev 6:928, 1992
17. Foley KP, Engel JD: Individual stage selector element mutations lead to reciprocal changes in beta- vs. epsilon-globin gene transcription: Genetic confirmation of promoter competition during globin gene switching. Genes Dev 6:730, 1992